Skip to main content

Marksans Pharma Ltd announces USFDA approval for Loratadine Liquid Filled Capsules 10 mg (ANDA 206214)

 

Clinical courses

 

Clinical courses

Marksans Pharma Limited announces that USFDA has granted approval for an Abbreviated New Drug Application (ANDA) for Loratadine Liquid Filled Capsules 10 mg.

Loratadine Liquid Filled Capsules 10 mg is therapeutically equivalent to the reference listed drug Claritin Liqui-Gels Capsules 10 mg of Bayer Flealthcare LLC.

Loratadine is an antihistamine that reduces the effects of natural chemical histamine in the body. Loratadine is used to treat sneezing, runny nose, watery eyes, hives, skin rash, itching and other allergy symptoms

<< Pharma News

Subscribe to PharmaTutor News Alerts by Email